EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Cardiac Rehabilitation for Cardiovascular Risk Modification in Patients With Rheumatoid Arthritis and Hypertension: A Randomized Controlled Trial

Abdurrahman Kutluca iD, Serap Tomruk Sütbeyaz, Havva Talay Çalış, Selami Demirelli, Emrah Çitil iD

International Journal of Rheumatic Diseases · 2026-07 · 29 (7)

DOI: 10.1111/1756-185x.70793 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 20.07.2026. Verfasst von Abdurrahman Kutluca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Kayseri City Training and Research Hospital, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Hypertension, Cardiac Rehabilitation, Risk Reduction Behavior. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease, particularly when hypertension coexists. However, evidence regarding the role of cardiac rehabilitation (CR) in this high‐risk population remains limited. In this randomized controlled trial, the effects of a structured CR program on estimated cardiovascular risk, ambulatory blood pressure, and cardiorespiratory fitness were evaluated in patients with RA and hypertension.

Methods

In this single‐center randomized controlled trial, 50 patients with RA and hypertension were randomly assigned (1:1) to a 6‐week supervised CR program or usual care. The intervention included supervised aerobic, resistance, and flexibility training together with weekly educational sessions. Outcomes were assessed at baseline and at 6, 12, and 24 weeks by blinded evaluators. The primary outcome was estimated 10‐year cardiovascular risk assessed using the Framingham Risk Score (FRS), with QRISK 3 analyzed as a supportive risk measure. Secondary outcomes included 24‐h ambulatory systolic blood pressure measured by ambulatory blood pressure monitoring (ABPM), cardiorespiratory fitness assessed by treadmill cardiopulmonary exercise testing (VO 2 max), and rheumatoid arthritis disease activity (DAS28‐CRP). Longitudinal changes were analyzed using linear mixed‐effects models according to the intention‐to‐treat principle.

Results

Linear mixed‐effects modeling demonstrated a significant group × time interaction for FRS ( p < 0.001). At Week 24, the between‐group difference in FRS was −5.02 points (95% CI −8.60 to −1.44; p = 0.007). QRISK 3 showed a similar directional reduction but did not reach statistical significance at Week 24 (−5.77 points; 95% CI −12.54 to 1.01; p = 0.094). Significant group × time interactions were also observed for 24‐h ambulatory systolic blood pressure ( p < 0.001) and VO 2 max ( p < 0.001). At Week 24, the between‐group difference was −9.70 mmHg for ambulatory systolic blood pressure and + 4.90 mL·kg −1 ·min −1 for VO 2 max. Disease activity remained within the remission range throughout follow‐up.

Conclusion

In selected patients with clinically stable rheumatoid arthritis and coexisting hypertension who were receiving stable pharmacologic therapy and were able to participate in supervised exercise, a structured cardiac rehabilitation program was associated with improvements in estimated cardiovascular risk profiles, ambulatory systolic blood pressure, and cardiorespiratory fitness without worsening disease activity. These findings support further evaluation of cardiac rehabilitation as an adjunctive strategy for cardiovascular risk management in a selected cardiometabolically high‐risk rheumatoid arthritis population with hypertension. Trial Registration The trial was registered at ClinicalTrials.gov Identifier: NCT06295848

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidHypertensionCardiac RehabilitationRisk Reduction BehaviorCardiovascular DiseasesExercise TherapyHumansFemaleMaleMiddle AgedTreatment OutcomeTime FactorsCardiorespiratory FitnessBlood PressureAgedHeart Disease Risk FactorsPatient Education as TopicRisk AssessmentBlood Pressure Monitoring, AmbulatoryRisk Factors

Stichwörter der Autor:innen

cardiac rehabilitationcardiovascular riskhypertensionrheumatoid arthritis

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
  • Department of Cardiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.

ORCID-Profile: Abdurrahman Kutluca, Emrah Çitil

Zitieren

APA

Kutluca, A., Sütbeyaz, S. T., Çalış, H. T., Demirelli, S., & Çitil, E. (2026). Cardiac Rehabilitation for Cardiovascular Risk Modification in Patients With Rheumatoid Arthritis and Hypertension: A Randomized Controlled Trial. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70793

Vancouver

Kutluca A, Sütbeyaz ST, Çalış HT, Demirelli S, Çitil E. Cardiac Rehabilitation for Cardiovascular Risk Modification in Patients With Rheumatoid Arthritis and Hypertension: A Randomized Controlled Trial. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70793

BibTeX
@article{Kutluca2026,
  author = {Kutluca, Abdurrahman and Sütbeyaz, Serap Tomruk and Çalış, Havva Talay and Demirelli, Selami and Çitil, Emrah},
  title = {Cardiac Rehabilitation for Cardiovascular Risk Modification in Patients With Rheumatoid Arthritis and Hypertension: A Randomized Controlled Trial},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {7},
  doi = {10.1111/1756-185x.70793}
}
Kostenlos starten →